IMVT: Immunovant, Inc.
Performance
IMVT +50.54%
Watchlist
Select an item
Summary
IMVT at a glance
IMVT returned +50.54% over the past year and +32.48% a year over five years. Its worst drop in that year was -40.55%, smaller than 37% of stocks on Redstone, and its Sharpe ratio of 0.91 beats 71% of stocks on Redstone. It pays no dividends.
Current Drawdown
-21.82%
Rolling Volatility
69.64%
Actions
Metrics
Risk Indicators
Alpha37.85%
Beta1.54x
Sharpe0.91
Sortino1.81
Omega1.20
Calmar1.25
Martin3.86
Profile
About IMVT
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $7.3B
- Listed
- Jun 2019
- Employees
- 315
- Headquarters
- Durham, NC
- Website
- immunovant.com
Comparisons